Clinical Trials · NCT02837783

A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)

Name: A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

TerminatedPhase 4Linaclotide

Phase: Phase 4
Recruitment status: Terminated
Sponsor: Ironwood Pharmaceuticals, Inc.
Enrollment: 20
Start date: Dec 2016
Locations: 1 site, United Kingdom
Primary endpoint: Change From Baseline in Abdominal Girth at Week 4

View Linaclotide compound reference